|
"lu y s"的相关文件
显示项目 421-430 / 467 (共47页)
<< < 38 39 40 41 42 43 44 45 46 47 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2015 |
Effect of Immunohistochemically Biological Expression on Clinical Outcome for Patients With Breast Cancer and 1-3 Positive Lymph Nodes After Mastectomy Without Adjuvant Radiation Therapy Under Present Day Systemic Treatment
|
Lai, S.; Huang, C. S.; Lu, Y. S.; Cheng, A. L.; Kuo, S. H.; 盧彥伸; 郭頌鑫; 鄭安理; 黃俊升 |
| 臺大學術典藏 |
2015 |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Lin C.-H.; Chen I.-C.; CHIUN-SHENG HUANG; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H. |
| 臺大學術典藏 |
2015 |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Cheng A.-L.; Shih T.T.-F.; CHIUN-SHENG HUANG; Huang S.-M.; Chao T.-C.; Chen B.-B.; Rau K.-M.; Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2015 |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Huang C.-S.; Hu F.-C.; Kuo W.-H.; KUAN-TING KUO; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H.; Chen W.-W.; Lu Y.-S.; Cheng A.-L.; Lin C.-H.; Chen I.-C. |
| 國立交通大學 |
2014-12-08T15:47:47Z |
Efficiency droop alleviation in InGaN/GaN light-emitting diodes by graded-thickness multiple quantum wells
|
Wang, C. H.; Chang, S. P.; Chang, W. T.; Li, J. C.; Lu, Y. S.; Li, Z. Y.; Yang, H. C.; Kuo, H. C.; Lu, T. C.; Wang, S. C. |
| 國立交通大學 |
2014-12-08T15:38:15Z |
Characteristics of efficiency droop in GaN-based light emitting diodes with an insertion layer between the multiple quantum wells and n-GaN layer
|
Chang, S. P.; Wang, C. H.; Chiu, C. H.; Li, J. C.; Lu, Y. S.; Li, Z. Y.; Yang, H. C.; Kuo, H. C.; Lu, T. C.; Wang, S. C. |
| 國立成功大學 |
2014-05-13 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2014 |
TOXICITY PROFILES OF ADJUVANT DOCETAXEL-CYCLOPHOSPHAMIDE IN ASIAN COMPARED WITH CAUCASIAN PATIENTS WITH BREAST CANCER
|
Chow, L. W. C.; Biganzoli, L.; Di Leo, A.; Kuroi, K.; Han, H. S.; Patel, J.; Huang, C. S.; Lu, Y. S.; Zhu, L.; Yip, A. Y. S.; Glueck, S.; Toi, M.; 盧彥伸; 黃俊升 |
| 國立臺灣大學 |
2013 |
Distant metastasis in triple-negative breast cancer
|
Tseng, L. M.; Hsu, N. C.; Chen, S. C.; Lu, Y. S.; Lin, C. H.; Chang, D. Y.; Li, H.; Lin, Y. C.; Chang, H. K.; Chao, T. C.; Ouyang, F.; Hou, M. F.; 盧彥伸; 張端瑩; 林璟宏 |
显示项目 421-430 / 467 (共47页)
<< < 38 39 40 41 42 43 44 45 46 47 > >>
每页显示[10|25|50]项目
|
